'Keep on keeping on': persistence with lipid-lowering treatment in familial hypercholesterolaemia

被引:0
作者
Hegele, Robert A. [1 ,2 ]
机构
[1] Western Univ, Robarts Res Inst, 4288A-1151 Richmond St North, London, ON N6A 5B7, Canada
[2] Western Univ, Dept Med, 4288A-1151 Richmond St North, London, ON N6A 5B7, Canada
基金
加拿大健康研究院;
关键词
CARDIOVASCULAR-DISEASE; ADHERENCE;
D O I
10.1093/eurjpc/zwac297
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:318 / 319
页数:2
相关论文
共 12 条
[1]  
Alonso R, 2023, EUR J PREV CARDIOL, V30, P320, DOI 10.1093/eurjpc/zwac277
[2]   The patient journey with proprotein convertase subtilisin/kexin type 9 inhibitors in community practice [J].
Bradley, Corey K. ;
Shrader, Peter ;
Sanchez, Robert J. ;
Peterson, Eric D. ;
Navar, Ann Marie .
JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (05) :725-734
[3]   Familial hypercholesterolaemia [J].
Defesche, Joep C. ;
Gidding, Samuel S. ;
Harada-Shiba, Mariko ;
Hegele, Robert A. ;
Santos, Raul D. ;
Wierzbicki, Anthony S. .
NATURE REVIEWS DISEASE PRIMERS, 2017, 3
[4]   A systematic review to assess adherence and persistence with statins [J].
Deshpande, Sohan ;
Quek, Ruben G. W. ;
Forbes, Carol A. ;
de Kock, Shelley ;
Kleijnen, Jos ;
Gandra, Shravanthi R. ;
Simpson, Ross J., Jr. .
CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (04) :769-778
[5]   Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe [J].
Khunti, Kamlesh ;
Danese, Mark D. ;
Kutikova, Lucie ;
Catterick, David ;
Sorio-Vilela, Francisco ;
Gleeson, Michelle ;
Seshasai, Sreenivasa Rao Kondapally ;
Brownrigg, Jack ;
Ray, Kausik K. .
JAMA NETWORK OPEN, 2018, 1 (08) :e185554
[6]   Thirty percent of children and young adults with familial hypercholesterolemia treated with statins have adherence issues [J].
Langslet, Gisle ;
Johansen, Anja K. ;
Bogsrud, Martin P. ;
Narverud, Ingunn ;
Risstad, Hilde ;
Retterstol, Kjetil ;
Holven, Kirsten B. .
AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 6
[7]  
Mach F, 2020, EUR HEART J, V41, P111, DOI [10.1093/eurheartj/ehz455, 10.15829/1560-4071-2020-3826]
[8]   The power of lipid registries for cardiovascular disease prevention [J].
Nishikido, Toshiyuki ;
Ray, Kausik K. .
CURRENT OPINION IN LIPIDOLOGY, 2021, 32 (06) :342-348
[9]   Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease [J].
O'Donoghue, Michelle L. ;
Giugliano, Robert P. ;
Wiviott, Stephen D. ;
Atar, Dan ;
Keech, Anthony ;
Kuder, Julia F. ;
Im, KyungAh ;
Murphy, Sabina A. ;
Flores-Arredondo, Jose H. ;
Lopez, J. Antonio G. ;
Elliott-Davey, Mary ;
Wang, Bei ;
Monsalvo, Maria Laura ;
Abbasi, Siddique ;
Sabatine, Marc S. .
CIRCULATION, 2022, 146 (15) :1109-1119
[10]   Proprotein convertase subtilisin/kexin type 9 inhibition as the next statin? [J].
Rakipovski, Gunaj ;
Hovingh, G. Kees ;
Nyberg, Michael .
CURRENT OPINION IN LIPIDOLOGY, 2020, 31 (06) :340-346